AI Is Raising Alarms. In Singapore, Nobel Laureates Want to See What It Can Discover

Artificial intelligence has acquired an unusual distinction. Some of the people racing hardest to build it are also warning most loudly about what could go wrong.

In a striking alignment, Anthropic CEO Dario Amodei recently called for the industry to slow the advance of increasingly capable models while stronger safeguards catch up. He was quickly joined by OpenAI CEO Sam Altman and tech titan Elon Musk, as concern grows over misuse, cyber risks and systems becoming harder to control.

But next month, five Nobel laureates will gather in Singapore to look at the other side of that coin. Their question is less about what AI might eventually do to humanity, and more about what scientists can get it to do for them.

At the Nobel Heroes & AI4SCI Summit, this flagship forum will run on October 5 and 6, bridging Nanyang Technological University and Singapore Management University. It will bring together researchers, tech executives and investors to discuss AI-driven scientific discovery, health, longevity and the future of work.

The forum is by invitation only. A portrait exhibition at Gardens by the Bay runs open to the public through to October 11. Symbiosis Science, Laureates City Holdings and Advaita Lab organise the event, hosted by the Lindau Nobel Laureate Meetings.

The summit’s line-up spans four fields of monumental complexity. In Physics, Konstantin Novoselov represents the frontier of materials science, having shared the 2010 Nobel with Andre Geim for isolating graphene. This one-atom-thick carbon sheet completely upended our understanding of material limits.

In 2021, Benjamin List shared the Chemistry Nobel with David MacMillan for developing asymmetric organocatalysis. It gave pharmaceutical chemists a radically cleaner and inexpensive way to construct the vital molecules that drugs depend on.

They are joined by the freshly minted 2025 laureates Fred Ramsdell and Omar M. Yaghi. Ramsdell shared the 2025 Medicine prize with Mary Brunkow and Shimon Sakaguchi for pioneering work on peripheral immune tolerance, unravelling the mechanisms that stop the body’s own immune cells from attacking healthy tissue.

Yaghi shared the 2025 Chemistry prize with Susumu Kitagawa and Richard Robson for developing highly porous metal-organic frameworks, which have opened entirely new pathways for carbon capture, water harvesting and energy storage.

Completing the cohort is economist Christopher Pissarides, who received the 2010 Economics prize for his search and matching theory. It is an analytical model governments and central banks use to understand why unemployment persists even when jobs exist. And it now frames much of the academic debate on automation and the future of work.

This makes for an intriguing contrast. At the commercial frontier of AI, safeguards and regulatory pacing have gridlocked the debate. In pure science, the bottleneck is the exact opposite. Too many molecules, materials and biological interactions exist for human minds to explore one by one. AI offers a way to narrow that infinite universe.

By sifting through billions of data points, advanced AI models can identify promising candidates and guide researchers towards experiments worth conducting in the physical world.

They do not make the laboratory redundant. They can, however, reduce the time spent pursuing dead ends—and that is particularly attractive in drug development and materials science, where years can separate an interesting hypothesis from something that can actually be manufactured, prescribed or commercialised.

Recognising this potential, Singapore has placed a sizeable bet on the proposition. The government committed S$120 Mn to its AI for Science initiative, a programme designed to bridge the gap between AI researchers and domain specialists in advanced materials, biomedical and health sciences. The programme also aims to build shared tools and datasets and improve access to computing resources for scientific research.

For a city-state whose deeptech ambitions depend on compressing the timeline between laboratory discovery and market readiness, the logic is entirely sound.

Singapore has been explicit about the potential. Government officials have highlighted AI’s ability to accelerate materials research, drug development and other areas where traditional discovery can take years or even decades.

The Nobel gathering puts some unusually accomplished scientists into that conversation. Graphene, metal-organic frameworks, organocatalysts, peripheral immune tolerance—these are precisely the fields where progress depends on searching through enormous numbers of possible answers before finding one worth pursuing.

The ultimate irony is that the same qualities making advanced AI unsettling to its creators—its capacity to reason, search and act with dwindling human intervention—are precisely what make it an invaluable tool for global science.

OpenAI itself is currently operating on both sides of this line. While publicly building safeguards, its internal researchers are already deploying AI coding agents to run complex experiments and fundamentally reshape their daily research loops.

Singapore’s initiative does not dissolve AI’s inherent risks, nor does it imply that scientific applications are entirely safe. However, it successfully shifts the narrative. Much of the global discourse obsessively asks what happens when machines become more capable than expected. The scientists gathering in Singapore will be asking a much more immediate question. What happens when those capabilities are deliberately pointed at problems humanity has spent centuries struggling to solve?

It may result in a more efficient semiconductor material or the isolation of a precise cancer drug molecule. But it will lack the cinematic drama of an uncontrollable superintelligence. Yet for a scientist who has spent a lifetime searching for a needle in a molecular haystack, it is considerably more useful.

And that is the lighter paradox Singapore will put on display next month. Silicon Valley is asking how to keep AI from getting away from us. Some of the world’s best scientists are coming to Singapore to see how much further it can help them go.